2020
DOI: 10.1007/s00262-020-02592-x
|View full text |Cite
|
Sign up to set email alerts
|

Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…The tumor microenvironment is particularly conducive to the development of M2 macrophages and myeloid-derived suppressor cells, which potently suppress the anti-cancer immune response. In comparison to their anti-tumor counterparts, these cells significantly upregulate the expression and activity of cysteine cathepsins (75,239). Blocking these cysteine cathepsins could inhibit their immunosuppressive functions, subsequently alleviating the tumor burden.…”
Section: Cathepsins and Their Inhibitors As Chemotherapeutic Targets For Modulating Immune Cell Functionsmentioning
confidence: 99%
“…The tumor microenvironment is particularly conducive to the development of M2 macrophages and myeloid-derived suppressor cells, which potently suppress the anti-cancer immune response. In comparison to their anti-tumor counterparts, these cells significantly upregulate the expression and activity of cysteine cathepsins (75,239). Blocking these cysteine cathepsins could inhibit their immunosuppressive functions, subsequently alleviating the tumor burden.…”
Section: Cathepsins and Their Inhibitors As Chemotherapeutic Targets For Modulating Immune Cell Functionsmentioning
confidence: 99%
“…For example, the inhibition of cathepsins influenced the development of osteoclasts from immunosuppressive myeloid-derived suppressor cells, which could contribute to bone metastases [47]. In contrast, the inhibition of cathepsin S was shown to convert regulatory T lymphocytes from immunosuppressive to immunostimulatory cells [48] and inhibition of cathepsin L enhanced cytotoxicity of CD8 + T cells in the co-culture model of tumour cells and myeloid-derived suppressor cells [25]. With this in mind, we investigated whether the inhibition of cathepsin X activity in cytotoxic cells influences LFA-1 affinity modulation, and thus effects formation of stable immunological synapse and cytotoxic activity of cells.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, it was shown that cathepsin X influences the reciprocal interactions between tumour cells and tumour promoting myeloid-derived suppressor cells (MDSC). Pharmacological tools for counterbalancing excessive proteolytic activity in tumour tissue might therefore have unexpected consequences for the function of immune cells [25]. Furthermore, the leukocyte specific β2 integrin receptors can be sequentially trimmed at C-terminus by cathepsin X, which modulates their association with adaptor proteins (talin, α-actinin) and fine-tunes their affinity for extracellular ligands [26].…”
Section: Introductionmentioning
confidence: 99%
“…Using Tick Cysteine Protease Inhibitor RHcyst-1, a cathepsin inhibitor and a member of the cystatin 1 family, can decrease and increase the activity of MDSCs in peripheral blood mononuclear cells (PBMC) and the spleen, respectively (102). In breast cancer, cathepsin L/X can also increase the activity of MDSCs in breast cancer and are related to breast cancer invasion (103). Cathepsin B also promotes the formation of neutrophil extracellular traps and modulates tumor aggressiveness in vitro (104).…”
Section: Tumor-associated Immune Cellsmentioning
confidence: 99%